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Exploring the views and experiences of HIV positive patients treated for 
cancer: a systematic review of the literature 
Abstract. Structured Summary 
Objective:  A systematic review of the literature was conducted to find out what is known 
about patients’ experiences of a dual diagnosis of HIV and cancer  
Design: A systematic review 
 Methods: We systematically searched the following databases; MEDLINE (Ovid Version); 
CINAHL Plus; PsycINFO and EMBASE   from inception to June 2016 for studies that 
included patients with a dual diagnosis of cancer and HIV and focused on patient 
experiences. Studies with a focus on one illness rather than a dual diagnosis, those that 
focused on treatment strategies and medical management, epidemiology and pathology 
studies and comparison studies were all excluded. The full text of the included studies was 
reviewed. Information on location, sample size, study design and a narrative summary of 
findings were extracted using a standardised format. Studies were combined thematically.   
Results: 1777 records were screened by title and abstract using the selection criteria 
described in the methods.  Eight records were reviewed in depth in full text and seven 
selected as eligible. The selected studies suggest that a dual diagnosis of HIV and cancer has 
a powerful impact on individuals’ behaviour.  The experience of stigma was a consistent 
factor in all patient accounts.   
Conclusions: This is an area largely unexplored in the published literature; further research 
into patients’ experiences of a dual diagnosis or HIV and cancer will provide relevant 
knowledge in order to tailor and improve services. (228 words) 
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Introduction 
Effective HIV treatment and continued HIV incidence means the number of people living 
with HIV/AIDS (PLHIV) has been increasing. Worldwide it reached 38·8 million in 2015. 
Wang et al. (2015). In the UK there were an estimated 107,800 PLHIV in 2013. Yin et al. 
(2014). One in four of PLHIV are now aged 50 years and over and consequently we are 
seeing more non AIDS-related malignancies in this ageing population and an associated 
increase in numbers of people with a dual diagnosis of HIV and Cancer needing to navigate 
two systems of specialised services. Those people with HIV who are more likely to develop 
malignancies; namely those who are diagnosed late with HIV or who are poorly engaged or 
disengaged with treatment, are a particularly vulnerable group. The START trial indicated 
that viral driven cancers such as Kaposi’s sarcoma and lymphoma occurred more often in 
those people who started HAART (Highly Active Antiretroviral Therapy) later (later in this 
case being a CD4 count less than 500 cells/mm3). INSIGHT START Study Group (2015). 
This group may pose a particular challenge to the provision of dual care in two conditions 
which are both serious and in which diagnosis can be distressing and frightening.  
As PLHIV increasingly engage with cancer services their experiences are important to inform 
healthcare provision. Outcomes for both conditions rely on engagement and trust in the health 
system and this will be influenced by their experiences. The National Cancer Patient 
Experience Survey of 2014 showed that patient groups with an existing chronic condition, or 
from an ethnic or sexual minority, were less likely to be positive about their experiences of 
cancer care and treatment. Quality Health (2014), Pinder, Ferguson and Moller (2016). 
Investigation into the views, attitudes and experiences of PLHIV who are often  from 
marginalised communities will provide insights which will allow care to be better tailored 
with the aim of improving outcomes. 
 
 
Literature which looks specifically at patients’ experiences is an important addition to the 
body of knowledge which has been used as a means to improve care in other disease areas 
such as diabetes self-management and adherence to breast cancer treatment. Heisler, 
Bouknight, Hayward, Smith & Kerr (2002); Kahn, Schneider, Malin & Epstein (2007).  An 
understanding of patients’ experiences can help to provide a context and explanation for 
issues such as late presentation with symptoms of HIV or cancer, information requirements 
around diagnosis and treatment and adherence to treatment for both conditions. There are 
strong links between being involved in decision-making and feeling information is 
communicated effectively and improved safety and better clinical outcomes. Doyle, Lennox 
& Bell (2013). For this particular group of patients it is important to identify the common 
drivers of good experience in order to inform improvement in services offered.   Ziebland and 
colleagues (2013) present patient experience as a key component of healthcare quality and 
this is reinforced by NHS policy drivers such as the NHS Constitution of 2015 and the 
responses to the Francis Report of the Mid-Staffordshire NHS Foundation Trust Public 
enquiry. Department of Health (2015), Mid Staffordshire NHS Foundation Trust (2013). For 
HIV services, data on patient experiences are vital for raising awareness around the 
experience of cancer and collaborative working with cancer services; from the cancer 
services perspective it is important to understand implications for the management of 
complex patients presenting with pre-existing conditions. 
Given the growing number of people who will be affected by a dual diagnosis of HIV and 
Cancer, many of whom will be from marginalised communities, the importance of 
understanding patients’ experiences in order to improve outcomes is an important area of 
enquiry.  
  
 
 
Methods 
A review of the literature relating to the experiences of HIV positive patients with a dual 
diagnosis of cancer was conducted. The review deliberately employed broad inclusion criteria 
and was constructed to include all study designs. Studies with a purely medical focus such as 
antiretroviral/chemotherapy management, epidemiology studies or those with a biology or 
pathology focus were excluded if they did not provide any perspective on patients’ 
experiences of care. 
 
Search strategy and selection criteria 
The following databases were searched from their inception to June 2016 : MEDLINE (Ovid 
Version); CINAHL Plus; PsycINFO; and EMBASE. These databases were selected to 
provide an extensive coverage of the biomedical literature as well as including literature from 
psychology, nursing and allied health fields where one might expect information on patients’ 
experiences to be found. Reference lists of included papers were reviewed and contact was 
made with authors. A university librarian provided expert guidance on the appropriate use of 
keyword and thesaurus terms within a comprehensive search strategy. The literature search 
used the following terms (with synonyms and closely related words): ‘cancer’ and ‘HIV’ or 
‘AIDS’ combined with [‘interviews as topic’ or ‘qualitative research’ or ‘experience’ or 
‘patient satisfaction’]  
The search was tailored to find research most likely to yield useful information on patient 
experience (defined by The Beryl Institute as ‘the sum of all interactions, shaped by an 
organisation’s culture, that influence patient perceptions across the continuum of care’). The 
Beryl Institute Website (Accessed February 2017).  Qualitative research was used as one of a 
number of terms to capture literature on experience but the overall search was not limited by 
 
 
research method, study design, country of origin or language of publication. An example of 
the full strategy and terms is provided in Table 1.  
 Ovid Medline Search 2nd August 2016  
 Search terms Results 
1 ((cancer* or neoplasm* or tumo?r* or carcinoma*) adj3 (diagnos* or 
treat* or therap*)).mp. 
429125 
2 exp Neoplasms/di, dt, pc, th 1092739 
3 1 or 2 1312382 
4 exp HIV/ 88751 
5 exp HIV Infections/ 249810 
6 (HIV or human immunodeficiency virus or acquired immunodeficiency 
syndrome).mp. 
353937 
7 AIDS-Related Opportunistic Infections/ 20260 
8 4 or 5 or 6 or 7 358830 
9 Interviews as Topic/ 48322 
10 Interview*.mp. 301485 
11 qualitative research/ 28387 
12 qualitative.mp. 168648 
13 experience*.mp. 832382 
14 px.fs. 852048 
15 exp Patient Satisfaction/ 70859 
16 Dual diagnosis/ 3240 
17 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 1872211 
18 3 and 8 and 17 761 
 
Records were screened by title and abstract to include all studies featuring a dual diagnosis of 
HIV and Cancer with a focus on patient experience, including the perspectives of both 
patients and service providers. Studies with a focus on just cancer or HIV rather than a dual 
diagnosis were screened out. Of the remaining studies those which focused exclusively on 
treatment strategies and medical management, epidemiology and pathology studies and 
comparison studies were all excluded. A sample of 10% of the dual diagnosis results was 
independently screened and checked using the exclusion criteria above. Figure 1 features a 
flow chart to summarise the process. The full text of the remaining studies was reviewed and 
information on location, sample size, study design, and narrative summaries of findings were 
recorded using a data extraction form. 
 
 
 
Figure 1 Search Strategy  
Records identified through 
database searching 
n = 2373 
Ovid Medline (n= 761) CINAHL Plus (n= 516) 
PsycINFO (n= 35)   EMBASE (n = 1061) 
 
 
 
 
Records after duplicates removed 
n = 1777 
(n = 55 Endnote program 
n = 541 handsifting by title) 
 
 Final Full-text articles 
assessed for eligibility 
n = 8   
Records screened n = 1777          
(title and abstract) 
n = 1777  
 
Records excluded  
n = 1548 (HIV/Cancer alone) 
n = 147  (Evaluation of 
drug/surgical/RT/imaging/transplant 
medical management) 
n = 40  (Epidemiology/risk factors) 
n = 16  (Pathology,virology study) 
n = 14  (Comparison studies) 
n = 4  (further duplicates) 
 
 Excluded n = 1 
(Discussion paper from 1996 focus on 
nursing care of physical symptoms) 
 
 
  
Selected papers 
n = 7 
(all of relevance, n=3 contain in 
depth exploration from patient 
perspective) 
 
 
Data Synthesis 
For each eligible study information about the sample such as the country it was drawn from 
and the gender and number of participants, along with a description of the research methods 
were noted. Studies were classified according to whether the aim was to represent service 
providers or the perspective of patients themselves. This process and the eligible studies are 
summarised in an evidence table, see Table 2.  
 
 
 
 
  
 
 
Table 2  
 
  
Reference Sample no Sample characteristics Location Date Question Design/Methods Results Comments
Two for the price of one: life with a dual 
diagnosis of HIV and Cancer Dodds N, HIV 
Nursing. 8(1): 5-5. 2008 n = 10
Small cohort of gay men 
with dual diagnosis of HIV 
and Cancer 
London HIV 
Oncology clinic 2008
To understand the meanings & language 
that this group of patients ascribe to their 
illness
Qual methods. 'Exploratory 
ethnographic study using 
observation and in depth 
interviews'
Findings include uncertain lead up 
to diagnosis,selective disclosure of 
illness, perception of 
guilty/innocent illness, lack of 
control with life-threatening nature 
of cancer. Explaining cancer, link to 
HIV, environment, stress
Small, single site, looking at gay men only. 
Very relevant in exploring patient 
experience as described by patients 
themselves.
The experience of African women 
diagnosed with both HIV/AIDS and 
cervical cancer. Maboko, E. Mavundla T.R. 
Africa Journal of Nursing and Midwifery 
8(1): 15-30. 2006 (MA in Public Health) n = 8
Purposive sample of 
African women aged 31-42 
years diagnosed with HIV 
and cervical cancer
Radiotherapy 
department 
Johannesburg 
hospital, South 
Africa 2006
How did the sample experience being 
diagnosed with both HIV/AIDS and 
cervical cancer?
Qual methods. In-depth 
phenomenological 
individual interviews and 
field notes
Themes emerge as importance of 
communication ; experience of 
physical symptoms and emotional 
experience
A qualitative study looking at dual diagnosis 
with HIV and cervical cancer. Findings 
around selective disclosure, useful. Physical 
symptoms less transferrable. Small sample, 
8 participants, one type of cancer. African 
setting.
Experiences of Batswana women 
diagnosed with both HIV/AIDS and 
cervical cancer. Molefe T; Duma SE. 
Curationis. 32(4): 29-39. 2009 n = 6
 Women diagnosed with 
HIV and cervical cancer 
Oncology & 
gynaecology 
department 
tertiary hospital, 
Botswana 2007
What are the experiences of Batswana 
women diagnosed with both HIV/AIDS 
and cervical cancer?
Qualitative methods. Semi-
structured interviews and 
field notes, 
phenomenological 
approach
Emergent themes, deep pain, fear 
of the future/dying, intimate 
loneliness, blaming others and 
themselves, hope and spiritual 
support, 
A qualitative study looking at dual diagnosis 
with HIV and cervical cancer. Does not 
explore how the 2 illnesses interplay, how 
they might differ from each other, rather the 
themes arise from one entity the dual 
diagnosis. Small sample, African setting, 
using convenience sample
Predictors of timely access of oncology 
services and advanced stage cancer in an 
HIV-endemic setting. Brown, C. A., et al. 
Oncologist 21(6): 731-738. 2016 n = 1,146 Oncology patients
Oncology 
services in 2 
hospitals in 
Southern 
Botswana 2014
Does engagement in longitudinal HIV care 
improve access to timely oncology care?
Baseline survey, and 
review of records for 
information on 
symptom/treatment 
history, HIV testing for 
those without a test in 
previous 6 months. 
Covariate descriptions and 
measurement of time to 
enrollment in oncology 
care
Longitudinal HIV care did not reduce 
the substantial delay to cancer 
treatment
Survey collecting demographic information. 
Interesting suggestion that receiving HIV 
care does not raise awareness of cancer 
symptoms and lead to earlier presentation
An innovative joint approach to HIV and 
lymphoma care. Dhairyawan, R., S. 
Longwill, et al. Sexually Transmitted 
Infections 88(1):71.2012. (Letter)
n = 73
Patients at novel specialist 
HIV-haemato-oncology 
clinic at London hospital
London NHS 
Trust
Nov 2009 - 
April 2010
Were patients satisifed with experience 
of specialist clinic?
Patient satisfaction 
survey.Questions about 
satisfaction with joint 
clinic, ability to discuss 
sensitive topics with 
sufficient time.  Response 
rate 66%
High level of satisfaction, some 
patients expressed desire for a 
support group Service evaluation, not peer reviewed, one 
clinic, letter,limited remit,  survey rather 
than qualitative enquiry into experience
Quality of life, characteristics and survival 
of patients with HIV and Lymphoma. 
Diamond C et al. Quality of Life Research. 
19(2):149-55, 2010
n = 100
50 patients with HIV 
&NHL, 50 patients with 
NHL and no HIV using 
population-based cancer 
registry for Orange & San 
Diego Counties
Cancer registry 
for Orange & San 
Diego Counties, 
California, US
Patients 
diagnosed 
2002 - 2006
How do quality of life, characteristics and 
survival compare between patients with 
non Hodgkins lymphoma with and 
without HIV?
Patients completed 
surveys: medical history, 
QOL, FAHI and FACT G
HIV infected NHL patients had 
worse QOL & survival than 
uninfected patients due to 
combination of co-morbidity, 
aggressive histology and lack of 
social support
Quantitative methods, focus just on HIV & 
lymphoma but is relevant for dual diagnosis, 
suggesting it may be more challenging for 
both medical & social reasons. Low social 
well-being scores in dual diagnosis
At the intersection of HIV/AIDS and 
cancer: a qualitative needs assessment of 
community-based HIV/AIDS service 
organizations. Burkhalter JE et al Health 
Education & Behavior. 40(4):493-503, 2013 
n = 10
3 x 7 representatives from 
community-based 
organisations serving 
people with HIV.
New York, US
4 month 
period 2009 - 
2010
To identify capacities, facilitators and 
barriers to the uptake of cancer-focused 
programmes by community organizations.
Focus groups made up of 
reps from community-
based organisations, 
analysis of themes from 
transcripts
Agencies have limited experience, 
need resources & collaborative 
partnerships to effectively 
incorporate cancer services, staff & 
clients need education, cancer care 
providers should be culturally 
competent
A qualitative study dealing with dual 
diagnosis but looking from the perspective 
of community based service providers not 
from the perspective of the patients 
themselves. Useful external light shed on 
perceptions of cancer care providers not 
being culturally competent
 
 
Results 
Study selection and characteristics 
The initial search strategy resulted in 1777 records which were screened by title and abstract 
using the selection criteria described in the methods. 1548 records were excluded as they 
dealt with HIV alone or Cancer alone. The remaining 229 records were screened and a 10% 
sample independently checked. The most frequent reason for exclusion was the study having 
a purely medical management focus; 147 records were excluded as they featured the 
evaluation of treatment strategies and clinical outcomes in the context of a dual diagnosis. 40 
studies reporting epidemiological data on the prevalence and incidence of malignancy 
amongst the HIV population were also excluded along with 16 that had a biological, 
pathology focus. 14 studies that included a comparison between the experience of cancer 
patients and that of HIV patients were omitted as we were interested in exploration of dual 
diagnosis. Four papers were found to be further duplicates.  
Eight full text records were reviewed in depth. One of these was excluded as a discussion 
paper; the remaining seven records all featured an aspect of the patient perspective and 
experience of a dual diagnosis of HIV and Cancer (see Table 2). Due to the small number of 
results and their disparate nature, the findings were combined thematically and summarised 
narratively. 
 
 
Patient perspective in studies employing a survey method 
Three studies represented patient experiences using cross-sectional surveys of patients with a 
dual diagnosis. Brown et al. (2016) conducted a survey in Botswana of 1,146 oncology 
patients collecting information on symptom and treatment history and offering HIV testing to 
those who had not had a test in the previous six months. They compiled covariate 
 
 
descriptions and measured time to enrolment in oncology care. They found that having been 
engaged in HIV care did not raise awareness of cancer symptoms and was not associated with 
an earlier presentation with them. Although this finding has interesting implications for HIV 
patients’ experience of their cancer diagnosis, suggesting as it does that continued follow up 
in HIV services does not provide the opportunities to diagnose cancer earlier, there are 
problems with generalising the findings from two Botswanan hospitals beyond this setting 
and in particular to services in the UK.  
In a US study Diamond, Taylor and Anton-Culver (2010)  administered validated Quality of 
Life instruments; the Functional Assessment of Human Immunodeficiency Virus Infection 
(FAHI) in 50 patients with both HIV and Non Hodgkins Lymphoma (NHL), and the 
Functional Assessment of Cancer Therapy – General (FACT G) in 50 patients with NHL 
alone. The patients with a dual diagnosis had worse quality of life and survival than 
uninfected patients due to a combination of co-morbidity, aggressive histology and lack of 
social support. The finding of lower social well-being scores in the dual diagnosis group is 
relevant to an exploration of the patient experience in this group, although the study does not 
explore this in any depth and is limited to one particular malignancy.  
The final survey was featured in a letter describing a service evaluation of a specialist HIV 
haemato-oncology clinic at a single London site; descriptive in nature and brief it represented 
patient experience by reporting 73 patients’ feedback on their satisfaction with the joint 
service in terms of it providing the ability to discuss sensitive topics and sufficient time to do 
so. There was an expressed desire among patients for a support group and specific 
information sheets but the findings reported lacked detail and depth. Dhairyawan, Longwill, 
Orkin & Montoto, (2012). 
 
  
 
 
Service provider perspective 
One of the selected papers looked at dual diagnosis from the perspective of the service 
provider rather than the patient. A US study conducted three focus groups over a four month 
period in New York City. The groups were each made up of seven representatives from 
community based organisations who were selected because of the diversity of the populations 
they served and their extensive knowledge of the services and structure of their agencies. The 
focus groups explored the views of community based HIV service providers on what 
facilitators and barriers existed for them in offering support and information about cancer. 
Burkhalter et al., 2013. This provided an interesting perception on relevant issues, for 
example, some providers’ perceptions of cancer services not being culturally competent, 
although it did not provide any direct information on patients’ views and experiences.  
 
Patient perspective in studies using qualitative methods 
Three papers featured patients’ perspectives of a dual diagnosis of HIV and Cancer using rich 
data which featured patients’ perceptions and understandings and represented experiences 
with a depth of insight. Maboko and Mavundla (2006) and Molefe and Duma (2009) 
described two Southern African studies using in depth interviews and a phenomenological 
approach to explore the experience of women diagnosed with HIV and cervical cancer. 
Maboko (2006) performed in depth interviews with eight women with this dual diagnosis, 
aged between 31 and 42 years who attended the radiotherapy department in a Johannesburg 
hospital. The findings revealed that some patients chose to selectively disclose their cancer 
diagnosis and not their HIV diagnosis as a strategy to access social support. This feature of 
dual diagnosis is potentially of wider relevance, despite the study being focussed on one 
particular cancer in a South African setting. Molefe (2009) conducted semi-structured 
interviews with six women with both HIV and cervical cancer who were recruited from the 
 
 
oncology and gynaecology department in a tertiary hospital in Botswana. This study 
described isolation amongst the women, some of whom found it hard to maintain intimate 
relationships following their diagnosis and experienced feelings of guilt around their 
situation.  
Dodds (2008) conducted an ethnographic study looking at a single UK site with a small 
cohort of ten gay men with a dual diagnosis of HIV and cancer. This study used observation 
and in-depth interviews to consider the meanings and language that patients ascribed to their 
illness. He found that different meanings and explanations were assigned to each condition 
and that having both diseases presented particular challenges including reinforcing 
experiences of stigma. Themes that emerged included a prolonged and difficult lead up to 
their cancer diagnosis and selective disclosure, with participants telling work colleagues, 
family and friends about their cancer diagnosis to elicit support whilst not disclosing their 
HIV status which they believed would carry the imputation of blame. These findings around 
selective disclosure support those of Maboko (2006). Perceptions of ‘guilt’ and ‘innocence’ 
in relation to illness were evident alongside patients’ personal explanations and beliefs about 
what had caused their cancer. This study provided a highly relevant insight into patients’ 
experiences of a dual diagnosis; it was, however, limited to a single site and a single cohort of 
gay men.  
 
Discussion 
This review found the experience of people living with a dual diagnosis of HIV and Cancer to 
be largely unexplored in the published literature.  Patients experience the two diagnoses in 
different ways, coloured by the powerful cultural meanings and health beliefs that both 
conditions arouse.  This impacts on the way in which they navigate social and healthcare; 
 
 
potentially impacting on health and quality of life outcomes.  Given the increased number of 
people internationally who will be living with dual diagnosis this suggests a need to explore 
this under researched area.  
The findings of the seven studies identified demonstrated  that both HIV and cancer are 
illnesses linked to powerful beliefs and given cultural meaning in a way which impacts on an 
individual’s sense of self, the way they behave and the social responses of others. Molefe 
(2009) described the increasing social isolation of women as a result of their dual diagnosis . 
A key theme emerging from both Maboko (2006) and Dodds (2008) was that of patients 
adopting a system of selective disclosure and talking primarily about their cancer diagnosis as 
a way of accessing social support. This differential disclosure in favour of their cancer 
diagnosis seemed to be a way of navigating stigma and negotiating complex social and health 
pathways. Other studies have identified this phenomenon in the dual diagnosis of HIV and 
other conditions. Accounts of patients with HIV and tuberculosis and HIV and Hepatitis C 
respectively, revealed how selective disclosure was adopted to manage stigma with both sets 
of participants sharing information about the illness that they felt to be less discrediting, with 
greater caution being applied to information about their HIV diagnosis. Daftary (2012); 
Lekas, Siegel, Leider (2011). Even though the samples were small and specific to very 
particular groups of patients the selected studies in this review all suggest that a dual 
diagnosis of HIV and cancer has a powerful impact on individuals behaviour and that stigma 
plays a key part. 
The evidence suggests that patients diagnosed late with HIV, those who have disengaged 
with treatment, and vertically infected people, are at particularly risk of developing the virally 
driven cancers (e.g. lymphoma, cervical cancer and Kaposi sarcoma). INSIGHT START 
Study Group (2015). These patients are likely to be a particularly vulnerable group, and 
possibly members of marginalised populations experiencing stigma from more than one 
 
 
social structural category for example being gay or a migrant. We know that experience of 
stigma and the fear of disclosure of HIV status can affect adherence to HIV medication. 
Ware, Wyatt & Tugenberg (2006). What is not known is how this HIV related stigma 
interplays with a patient’s presentation with symptoms of cancer and adherence to cancer 
treatments.  
Recent policy and practice discourse has framed HIV as a chronic disease like any other 
managed by routine medical management. Flowers (2010). This normalisation narrative in 
HIV relies upon the success of treatment and a focus on positive and healthy living. 
Mazanderini and Paparini (2015) have shown that tensions, challenges and contradictions to 
this narrative appear when stigma continues to affect people’s work opportunities, social 
support systems and family life. When people with HIV experience health problems that 
don’t match the normalised depiction they experience further discrimination from community 
groups who had embraced this approach. It is important to explore in future research how 
much a cancer diagnosis acts as a challenge to this HIV normalisation narrative.  
 
Limitations 
Publication bias may be a limitation of this review with the published data featuring empirical 
studies relating to the medical management of dual diagnosis, while the patients’ experiences 
may feature more in the grey literature. There were a limited number of studies which it was 
not possible to combine making it harder to produce generalisable findings with confidence. 
Patient experience as a term is not always a clearly and consistently defined concept and this 
makes it difficult use in a systematic search of databases.  
 
 
 
Conclusions 
This literature review suggests that further exploration of patients’ experiences in the field of 
HIV and cancer dual diagnosis will add new knowledge relevant for tailoring improved 
services. The emerging themes around stigma and its effect on patients’ access to social 
support and engagement with services suggest that future research should adopt methods 
which explore this complexity, capture change over time and generate deeper understandings 
of patients’ behaviour. Patient agency interplays with stigma as can be seen with the strategy 
of selective disclosure; gaining a better understanding of this would provide opportunities to 
intervene and support service users. Such research in the future will help to provide a greater 
understanding of a dual diagnosis of cancer and HIV and how this can be managed most 
effectively for all concerned.    
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